- Issuer ticker
-
TPST
- Reported as of
-
27 Jan 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
28 Jan 2026, 16:30:08 UTC
Filing notes and source
Key filing fact
Michael Raab filed Form 4 for Tempest Therapeutics, Inc. (TPST) on 28 Jan 2026.
Key facts
- This page summarizes Michael Raab's Form 4 filing for Tempest Therapeutics, Inc. (TPST).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Jan 2026, 16:30.
Change
- Previous filing in this sequence was filed on 26 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001321402
Primary reporting owner
RAAB MICHAEL
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TPST
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,230
- Change %
- Price
-
$0.000000
- Shares after
- 1,230
- Date
- 27 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,230
- Exercise price
- $2.94
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote